Doctors can prescribe “forest bathing” to get their patients into the great outdoors to reduce stress and stress hormones.
Daniel G. Arkfeld, MD, talks about how sex and gender can play a role in the management of rheumatoid arthritis and in the development of effective disease control measures for patients.
Sandra Springer, MD, and Laura Marks, MD, PhD, highlight the need for a combined treatment approach for patients with drug-use associated infections.
An overview of the comorbidities and multimorbidities among older adults with inflammatory rheumatic diseases, and the challenges and considerations in the management of these patients.
The British Society for Rheumatology developed guidelines for the management of idiopathic inflammatory myopathy among pediatric and adult patients.
David Dickerson, MD, chair of the ASA Committee on Pain Medicine, discusses suggested changes and recommendations to the proposed clinical practice guidelines for prescribing opioids that were recently issued by the CDC.
Authors outline the efficacy and safety of topical NSAIDs for the treatment of acute and chronic musculoskeletal pain conditions including osteoarthritis.
The EULAR and ACR developed evidence-based guidance and points-to-consider for the diagnosis and management of patients with CANDLE/PRAAS, SAVI, and AGS.
The American College of Rheumatology, in conjunction with the Vasculitis Foundation, developed guidelines for rheumatologists for the management of Kawasaki disease.
Graham M. Snyder, MD, MS, provides further insight into a study that evaluated the effects of an early return-to-work program that reduced the quarantine period for clinicians who remained asymptomatic after exposure to COVID-19.